These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 15569991

  • 1. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L, Vidriales MB, García-Laraña J, Sanz G, Moreno MJ, López A, Barrena S, Martínez R, Tormo M, Palomera L, Lavilla E, López-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A.
    Clin Cancer Res; 2004 Nov 15; 10(22):7599-606. PubMed ID: 15569991
    [Abstract] [Full Text] [Related]

  • 2. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L, Vidriales B, García-Laraña J, López A, Martínez R, Martín-Reina V, Tormo M, González-San Miguel JD, Lavilla E, García-Boyero R, Orfao A, San Miguel JF, PETHEMA Cooperative Group.
    Haematologica; 2001 Dec 15; 86(12):1287-95. PubMed ID: 11726321
    [Abstract] [Full Text] [Related]

  • 3. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
    Suárez L, Vidriales MB, Moreno MJ, López A, García-Laraña J, Pérez-López C, Tormo M, Lavilla E, López-Berges MC, de Santiago M, San Miguel JF, Orfao A, PETHEMA Cooperative Group.
    Haematologica; 2005 Jan 15; 90(1):54-9. PubMed ID: 15642669
    [Abstract] [Full Text] [Related]

  • 4. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J, Shao ZH, Liu H, Jia HR, Sun J, Bai J, Wu YH, Jing LP, He GS, Cao YR, Wang XL, Tu MF, Hao YS, Yang TY.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov 15; 25(11):641-4. PubMed ID: 15634564
    [Abstract] [Full Text] [Related]

  • 5. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C, Hassan HT.
    Leuk Res; 2006 Mar 15; 30(3):296-302. PubMed ID: 16112192
    [Abstract] [Full Text] [Related]

  • 6. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL.
    Semin Hematol; 1997 Oct 15; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [Abstract] [Full Text] [Related]

  • 7. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, Sapia S, Pavlovsky S.
    Cytometry B Clin Cytom; 2006 Mar 15; 70(2):63-70. PubMed ID: 16470534
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
    Damiani D, Michieli M, Ermacora A, Candoni A, Raspadori D, Geromin A, Stocchi R, Grimaz S, Masolini P, Michelutti A, Scheper RJ, Baccarani M.
    Haematologica; 1998 Apr 15; 83(4):290-7. PubMed ID: 9592977
    [Abstract] [Full Text] [Related]

  • 9. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C.
    Clin Cancer Res; 2004 Jun 01; 10(11):3737-44. PubMed ID: 15173080
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick MB.
    Gynecol Oncol; 2006 Jan 01; 100(1):152-9. PubMed ID: 16198399
    [Abstract] [Full Text] [Related]

  • 11. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
    van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, Ossenkoppele GJ, Schuurhuis GJ.
    Haematologica; 2003 May 01; 88(5):497-508. PubMed ID: 12745269
    [Abstract] [Full Text] [Related]

  • 12. P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
    Tóthová E, Elbertová A, Fricová M, Kafková A, Hlebasková M, Svorcová E, Stecová N, Guman T, Raffac S.
    Neoplasma; 2001 May 01; 48(5):393-7. PubMed ID: 11845985
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD.
    Haematologica; 2000 Jul 01; 85(7):711-21. PubMed ID: 10897123
    [Abstract] [Full Text] [Related]

  • 14. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
    de Melo Campos P, Traina F, da Silva Santos Duarte A, Lorand-Metze I, Costa FF, Saad ST.
    Leuk Res; 2007 Jun 01; 31(6):853-7. PubMed ID: 17270269
    [Abstract] [Full Text] [Related]

  • 15. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
    Boudard D, Vasselon C, Berthéas MF, Jaubert J, Mounier C, Reynaud J, Viallet A, Chautard S, Guyotat D, Campos L.
    Am J Hematol; 2002 Jun 01; 70(2):115-25. PubMed ID: 12111784
    [Abstract] [Full Text] [Related]

  • 16. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
    Kurata M, Hasegawa M, Nakagawa Y, Abe S, Yamamoto K, Suzuki K, Kitagawa M.
    Exp Mol Pathol; 2006 Dec 01; 81(3):249-54. PubMed ID: 16566920
    [Abstract] [Full Text] [Related]

  • 17. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ, Fu R, Wang HQ, Yue LZ, Liu H, Wang J, Wang HL, Ruan EB, Qu W, Liang Y, Wang GJ, Wang XM, Liu H, Song J, Wu YH, Xing LM, Guan J, Shao ZH.
    Zhonghua Yi Xue Za Zhi; 2011 Jan 25; 91(4):234-8. PubMed ID: 21418866
    [Abstract] [Full Text] [Related]

  • 18. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P.
    Ann Hematol; 2006 Feb 25; 85(2):95-101. PubMed ID: 16328478
    [Abstract] [Full Text] [Related]

  • 19. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
    Tavil B, Cetin M, Tuncer M.
    Leuk Res; 2006 Feb 25; 30(2):222-4. PubMed ID: 16098587
    [Abstract] [Full Text] [Related]

  • 20. [Multidrug resistance markers monitoring in acute myeloid leukemia cells].
    Jankovicová K, Krejsek J, Kopecký O, Voglová J, Novosad J.
    Cas Lek Cesk; 2004 Feb 25; 143(7):471-5. PubMed ID: 15373290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.